The precautionary principle in times of intermingled uncertainty and risk: some regulatory complexities

This article explores the use of the precautionary principle in situations of intermingled uncertainty and risk. It analyses how the so-called uncertainty paradox works out by examining the Pfizer case. It reveals regulatory complexities that result from contradictions in precautionary thinking. In conclusion, a plea is made for embedment of uncertainty information, while stressing the need to rethink regulatory reform in the broader sense.